Ben Stevens
Ben is the editor of Business of Cannabis. Since 2021, he has researched, written, and published the vast majority of the outlet’s content, delivering agenda-setting journalism on regulation, business strategy, and policy across Europe.
Ben Stevens · page 28
- Uncategorized
Small Island, Big Vision: Medical Cannabis as a Catalyst for Economic Growth
Most people associate the Isle of Man with its world-famous TT motorcycle races or its well-established financial services sector. But quietly and confidently, our Island is taking bold steps towards building one of Europe’s most exciting and high-potential new industries: medicinal cannabis.
- Uncategorized
Business of Cannabis Awards 2025: We Have Our Winners
The shortlist for the second annual Business of Cannabis Awards, Europe’s leading celebration of excellence across the cannabis sector, have been announced today.
- Events
Cannabis Europa 2025 – Key Insights Day 2
Below, we’ve summarised the key insights from the vibrant and diverse discussions throughout Day 2 of Cannabis Europa 2025. If you’re keen to dive into the details, we’ll be exploring each session in more detail over the coming weeks.
- Uncategorized
Cannabis Europa 2025 – Key Insights Day 1: Part 2
We’ve summarised the key insights from the vibrant and diverse discussions throughout the second part of Day 1 of Cannabis Europa 2025. If you’re keen to dive into the details, we’ll be exploring each session in more detail over the coming weeks.
- Uncategorized
Cannabis Europa 2025 – Key Insights Day 1: Part 1
Today, Cannabis Europa 2025 welcomed hundreds of the world’s leading cannabis voices for its first jam packed day of sessions.
- Hemp Industry
‘Seminal Moment’: Texas Hemp-Killing Bill Blocked as State Doubles Down on Medical Cannabis
Texas medical cannabis and hemp businesses both enjoyed some major, yet largely unexpected news over the weekend, not only ensuring the continued legality of hemp but significantly expanding the state’s medical cannabis programme.
- Press releases
Dalgety Signs Strategic Partnership with Curaleaf Laboratories
Dalgety, a UK-based EU-GMP certified medical cannabis cultivator, is pleased to announce a strategic partnership with Curaleaf Laboratories, a trusted name in cannabis medicine and pharmaceutical-quality cannabinoid innovation.
- Press releases
Glass Pharms Signs Supply Deal with Mamedica in ‘Milestone for UK Cultivation’
Under the collaboration, Glass Pharms will supply high-quality cannabis flower for use in Mamedica-branded, clinician-prescribed products, reinforcing the value of a fully domestic supply chain for CBPMs (Cannabis-Based Products for Medicinal Use).
- Uncategorized
Key Insights from Mary Jane Berlin x Business of Cannabis’ Inaugural B2B Day
European Cannabis Week 2025 has officially begun, seeing thousands of Europe’s cannabis thought leaders, innovators and decision makers descend on Berlin’s vast Messe Berlin for the first day of Mary Jane Berlin.
- Uncategorized
Congress Amends Language of Potential Hemp-Killing Bill, But Industry Warns Non-Intoxicating Hemp Still Under Existential Threat
The ongoing battle to rescue the US hemp industry has reached boiling point, as the 2026 spending bill continues to advance.
- Opinion
‘Europe Risks Legislating Without Execution’: The Entourage Effect CEO on What Europe Needs to Scale
Ahead of the Cannabis Europa 2026, which kicks off next Tuesday (June 24) at the Barbican Centre, we caught up with Eidan Havas, the Founder of one of Australia’s leading medical cannabis product wholesalers, The Entourage Effect.
- Medical
‘Access to Treatment Is Now a Right, Not a Privilege’: Ukraine Approves First Medical Cannabis Imports in Major Step Toward Access
Ukraine has issued its first medical cannabis import permit, marking a major milestone in its treatment rollout despite war-related regulatory challenges.
